Presentations

The Science of CardiAMP Cell Therapy
BioCardia Presentation at Forum for Innovative Regenerative Medicine (Tokyo, Japan)
Meeting on the Mesa "Successful Strategies in the Design and Delivery of a Cell/Gene Therapy Clinical Development Program"

Events

October 2019

Date: October 28-29, 2019
Location: Jupiter, FL
Event: Dawson James Securities 5th Annual Small Cap Growth Conference
To register and view a LIVE broadcast, click here

May 2019

Date: May 8-11, 2019
Location: San Francisco, CA
Event: 40th Annual Heart Rhythm Society Scientific Sessions

March 2019

Date: March 21, 2019
Location: New York, NY
Event: Cell & Gene Therapy Investor Day

January 2019

Date: January 7-10, 2019
Location: San Francisco, CA
Event: JP Morgan Healthcare Conference

November 2018

Date: November 12, 2018
Location: Chicago, IL
Event: American Heart Association Scientific Sessions 2018 Conference
Title: "The CardiAMP Heart Failure Trial: Efficacy Outcomes from Roll-In Phase"

October 2018

Date: October 3, 2018
Location: La Jolla, CA
Event: 2018 Cell & Gene Meeting on the Mesa
Title: "Successful Strategies in the Design and Delivery of a Cell/Gene Therapy Clinical Development Program"

Date: October 5, 2018
Location: Houston, TX
Event: 2018 Texas Heart Institute International Symposium on Cardiovascular Regenerative Medicine
Title: "The CardiAMP Heart Failure Trial"

September 2018
Date: September 24, 2018
Location: San Diego, CA
Event: 2018 Transcatheter Cardiovascular Therapeutics Conference
Title: "The CardiAMP Heart Failure Study: First Results from Unblinded Roll-In Phase"

Date: September 24, 2018
Location: San Diego, CA
Event: 2018 Transcatheter Cardiovascular Therapeutics Conference
Title: "Performance of Helix Transendocardial Biotherapeutic Delivery System after 300 Cases"



News


Have questions?
CALL US NOW
: (800) 624-1179
Have questions?
EMAIL US NOW
: info@biocardia.com

biocardia takes a new and comprehensive
approach to heart failure

By introducing patient screening and highly-efficient delivery to stem cell therapy, the company seeks to increase the likelihood of treatment success, enabling more patients to return to the things they love.